Table 6 The treatment methods with regards to the frequency of additional malignancies in studied cohort
Total | Additional malignancies | Others | p-value | |||
|---|---|---|---|---|---|---|
after UM | before UM | |||||
N = 644 | N = 73 | N = 48 | N = 523 | |||
Surgical treatment | Enucleation | 339 / 52,6% | 39 / 53% | 26 / 54% | 274 / 52,4% | 0,92144* |
Resection | 40 / 6,2% | 5 / 6,8% | 1 / 2,1% | 34 / 6,5% | ||
Endoresection | 4 / 0,6% | 0 | 0 | 4 / 0,8% | ||
Exenteration | 3 / 0,5% | 1 / 1,4% | 0 | 2 / 0,4% | ||
No treatment | 7 / 1,1% | 0 | 1 / 2,1% | 6 / 1,1% | ||
Total | 393 / 61,0% | 45 / 61,6% | 28 / 58,3% | 320 / 61,2% | ||
Radiation treatment | Ru-106 brachytherapy | 209 / 32,5% | 27 / 37,0% | 15 / 31,3% | 167 / 31,9% | |
TTT | 25 / 3,9% | 1 / 1,4% | 3 / 6,3% | 21 / 4,0% | ||
SRT | 17 /2,6% | 0 | 2 / 4,2% | 15 / 2,9% | ||
Total | 251 / 39,0% | 28 / 38,4% | 20 / 41,7% | 203 / 38,8% | ||